AnalystsAmi FadiaAmi Fadia's Stock Forecasts
AnalystsAmi Fadia
Analyst Ranking
Top 2%
#76 out of 4995 analysts
Average Return
+12.68%
Win Rate
54%221 out of 406
Risk vs Reward
Poor
Good
Ami Fadia's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Immuneering CorpIMRX | +294.35% | $1.24 | $4.89 | 2025-04-09 - 2025-08-22 | Buy |
Immuneering CorpIMRX | +208.77% | $1.14 | $3.52 | 2024-08-06 - 2025-08-06 | Buy |
Revolution Medicines IncRVMD | +176.50% | $21.49 | $59.42 | 2023-11-06 - 2024-11-06 | Buy |
Immuneering CorpIMRX | +171.67% | $1.80 | $4.89 | 2025-03-20 - 2025-08-22 | Buy |
Revolution Medicines IncRVMD | +156.77% | $18.36 | $47.13 | 2023-10-22 - 2024-10-22 | Buy |
Ami Fadia Analyst Color
Get additional color on Ami Fadia's coverage of popular stocks
Ami Fadia's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Jazz Pharmaceuticals PLCJAZZ | 30 | Buy | $202.00 | +64.08% | Reiterates | 3 days ago |
Revolution Medicines IncRVMD | 25 | Buy | $56.00 | +51.31% | Maintains | 16 days ago |
Merus NvMRUS | 30 | Buy | $96.00 | +42.24% | Maintains | 17 days ago |
Day One Biopharmaceuticals IncDAWN | 21 | Buy | $16.00 | +122.22% | Maintains | 17 days ago |
Axsome Therapeutics IncAXSM | 15 | Buy | $150.00 | +26.57% | Reiterates | 19 days ago |
Alkermes PLCALKS | 3 | Buy | $45.00 | +51.26% | Reiterates | 25 days ago |
Acadia Pharmaceuticals IncACAD | 10 | Buy | $30.00 | +16.55% | Reiterates | 2 months ago |
Immuneering CorpIMRX | 17 | Buy | $9.00 | +84.05% | Reiterates | 2 months ago |
Praxis Precision Medicines IncPRAX | 12 | Buy | $80.00 | +64.00% | Reiterates | 2 months ago |
Blueprint Medicines CorpBPMC | 31 | Hold | $130.00 | +0.42% | Downgrades | 3 months ago |
Centessa Pharmaceuticals PLCCNTA | 1 | Buy | $35.00 | +105.76% | Initiates Coverage On | 3 months ago |
Neumora Therapeutics IncNMRA | 9 | Buy | $5.00 | +208.64% | Reiterates | 3 months ago |
Avadel Pharmaceuticals PLCAVDL | 35 | Buy | $19.00 | +24.67% | Reiterates | 4 months ago |
Harmony Biosciences Holdings IncHRMY | 37 | Buy | $49.00 | +29.42% | Reiterates | 4 months ago |
Neurocrine Biosciences IncNBIX | 2 | Buy | $139.00 | +2.64% | Maintains | 4 months ago |
Bicycle Therapeutics PLCBCYC | 20 | Buy | $29.00 | +308.45% | Reiterates | 4 months ago |
Intra Cellular Therapies IncITCI | 26 | Hold | $100.00 | -24.17% | Downgrades | 7 months ago |
Cogent Biosciences IncCOGT | 21 | Hold | $15.00 | +23.76% | Downgrades | 8 months ago |
Biogen IncBIIB | 36 | Hold | $270.00 | +93.81% | Downgrades | 9 months ago |
Sage Therapeutics IncSAGE | 6 | Buy | $70.00 | N/A | Reiterates | 2 years ago |
Theseus Pharmaceuticals IncTHRX | 5 | Buy | $23.00 | N/A | Reiterates | 2 years ago |
Seagen IncSGEN | 6 | Buy | $185.00 | N/A | Maintains | 2 years ago |
Mirati Therapeutics IncMRTX | 1 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Amryt Pharma PLCAMYT | 1 | Buy | $40.00 | N/A | Initiates Coverage On | 5 years ago |
Myovant Sciences LtdMYOV | 3 | Hold | $26.00 | N/A | Maintains | 5 years ago |
Amarin Corp PLCAMRN | 2 | Buy | $320.00 | N/A | Maintains | 5 years ago |
Pacira Biosciences IncPCRX | 3 | Hold | $75.00 | N/A | Downgrades | 5 years ago |
Obseva SaOBSVF | 1 | Buy | $5.00 | N/A | Maintains | 5 years ago |
Amag Pharmaceuticals IncAMAG | 1 | Hold | $13.65 | N/A | Maintains | 5 years ago |
Iterum Therapeutics PLCITRM | 4 | Hold | $22.50 | N/A | Maintains | 5 years ago |
Perrigo Co PLCPRGO | 3 | Buy | $63.00 | N/A | Maintains | 5 years ago |
Rvl Pharmaceuticals PLCRVLPQ | 1 | Buy | $10.00 | N/A | Initiates Coverage On | 5 years ago |
Teva Pharmaceutical Industries LtdTEVA | 1 | Hold | N/A | N/A | Upgrades | 7 years ago |
Endo International PLCENDPQ | 1 | Buy | $12.00 | N/A | Initiates Coverage On | 8 years ago |
Heron Therapeutics IncHRTX | 1 | Buy | $22.00 | N/A | Initiates Coverage On | 8 years ago |
Scpharmaceuticals IncSCPH | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 8 years ago |
Alder Biopharmaceuticals IncALDR | 1 | Strong Sell | $13.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.